Reeve Emma Insider Trading Activity
Reeve Emma has been net-selling over the last 12 months with 0 purchases and 19 sales across 1 company.
PTCT is the most-traded position with 19 trades. The largest single transaction was a sale of PTCT for $834K on Oct 30, 2025.
Performance Scorecard
Forward stock performance after each transaction by Reeve Emma. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -4.9% | 16% | 19 |
| 90 days | — | -11.5% | 21% | 19 |
| 120 days | — | -9.4% | 32% | 19 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersPTCT · PTC THERAPEUTICS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Reeve Emma bought and sold PTCT.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jan 5, 2026 | PTCT | Sell | 734 | $76.00 | $56K | −6.4% | Director | |
Dec 3, 2025 | PTCT | Sell | 733 | $78.62 | $58K | −9.9% | Director | |
Nov 21, 2025 | PTCT | Sell | 10,000 | $79.50 | $795K | −60.0% | Director | |
Nov 12, 2025 | PTCT | Sell | 7,333 | $74.50 | $546K | −52.4% | Director | |
Oct 30, 2025 | PTCT | Sell | 3,666 | $69.50 | $255K | −35.5% | Director | |
Oct 30, 2025 | PTCT | Sell | 12,000 | $69.50 | $834K | −64.3% | Director | |
Oct 3, 2025 | PTCT | Sell | 3,028 | $65.09 | $197K | −14.9% | Director | |
Oct 3, 2025 | PTCT | Sell | 4,591 | $66.09 | $303K | −26.5% | Director | |
Oct 3, 2025 | PTCT | Sell | 2,381 | $66.87 | $159K | −18.7% | Director | |
Oct 3, 2025 | PTCT | Sell | 2,163 | $65.02 | $141K | −12.5% | Director | |
Oct 3, 2025 | PTCT | Sell | 3,149 | $66.11 | $208K | −20.9% | Director | |
Oct 3, 2025 | PTCT | Sell | 1,600 | $66.93 | $107K | −13.4% | Director | |
Oct 3, 2025 | PTCT | Sell | 2,729 | $65.05 | $178K | −14.4% | Director | |
Oct 3, 2025 | PTCT | Sell | 4,037 | $66.10 | $267K | −24.8% | Director | |
Oct 3, 2025 | PTCT | Sell | 1,884 | $66.89 | $126K | −15.4% | Director | |
Sep 11, 2025 Filed 3d late | PTCT | Sell | 3,534 | $59.50 | $210K | −23.3% | Director | |
Sep 11, 2025 Filed 3d late | PTCT | Sell | 1,334 | $59.50 | $79K | −11.4% | Director | |
Sep 11, 2025 Filed 3d late | PTCT | Sell | 10,000 | $59.50 | $595K | −49.2% | Director | |
Sep 11, 2025 Filed 3d late | PTCT | Sell | 837 | $59.50 | $50K | −7.5% | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| PTCT | PTC THERAPEUTICS, INC. | 19 | $5.2M |
Other insiders at PTC THERAPEUTICS, INC.
10 other tracked filers at PTCT.
VP
65
Trades
CHIEF TECHNICAL OPS OFFICER
49
Trades
CHIEF BUSINESS OFFICER
31
Trades
CEO
13
Trades
Director
12
Trades
VP
6
Trades
Director
4
Trades
VP
4
Trades
Director
3
Trades
CFO
3
Trades